Valuation: Clene Inc.

Market Cap 6.98Cr 6.12Cr 5.7Cr 5.24Cr 9.83Cr 666.55Cr 10Cr 68Cr 26Cr 330.57Cr 26Cr 26Cr 1.14TCr P/E 2026 *
-3.06x
P/E 2027 * -3.71x
Enterprise Value 5.64Cr 4.95Cr 4.61Cr 4.24Cr 7.94Cr 538.53Cr 8.08Cr 55Cr 21Cr 267.08Cr 21Cr 21Cr 922.75Cr EV / Sales 2026 *
272x
EV / Sales 2027 * 2.05x
Free-Float
82.94%
Yield 2026 *
-
Yield 2027 * -
1 day-8.61%
1 week-12.91%
Current month-18.93%
1 month-17.66%
3 months-17.66%
6 months-3.85%
Current year-14.99%
1 week 4.89
Extreme 4.89
5.96
1 month 4.89
Extreme 4.89
6.55
Current year 3.88
Extreme 3.88
8.67
1 year 3.25
Extreme 3.25
13.5
3 years 2.28
Extreme 2.2801
15.8
5 years 2.28
Extreme 2.2801
196.8
10 years 2.28
Extreme 2.2801
356.4
Manager TitleAgeSince
Chief Executive Officer 59 01/04/2013
Chief Tech/Sci/R&D Officer 67 01/01/2013
Director of Finance/CFO 57 01/02/2022
Director TitleAgeSince
Chairman 65 01/11/2015
Director/Board Member 53 01/09/2019
Director/Board Member 49 01/12/2020
Date Insider Type Main position Quantity % Market Cap.
11/06/26 Free

Founder

45,000 0.3522%
11/06/26 Free

Chief Financial Officer

15,000 0.1174%
11/06/26 Free

Chief Executive Officer

65,000 0.5087%
Change 5-day change 1-year change 3-year change Capi.($)
-8.61%-12.91%+36.71%-65.92% 6.98Cr
-2.25%+2.44%+53.17%+64.57% 5.62TCr
-1.32%-0.97%+38.41%+77.52% 5.48TCr
+1.49%+0.31%-19.82%-11.95% 2.3TCr
-0.57%-2.70%+0.17%+410.44% 2.27TCr
-0.21%+0.84%+22.48%-7.92% 2.02TCr
0.00%+3.30%+28.01%-29.07% 1.78TCr
-0.97%+0.89%+37.28%+539.62% 1.57TCr
-6.69%-5.11%+166.00%+304.89% 1.52TCr
+1.25%+1.76%+23.93%+188.32% 1.4TCr
Average -1.79%-0.49%+38.63%+147.05% 2.4TCr
Weighted average by Cap. -1.18%+0.42%+37.72%+133.32%

Financials

2026 *2027 *
Net sales 2L 2L 2L 2L 3L 1.98Cr 3L 20.11L 8L 98.27L 8L 8L 3.4Cr 2.36Cr 2.08Cr 1.93Cr 1.78Cr 3.33Cr 225.89Cr 3.39Cr 23Cr 8.97Cr 112.03Cr 8.88Cr 8.68Cr 387.05Cr
Net income -2.51Cr -2.2Cr -2.05Cr -1.89Cr -3.54Cr -239.73Cr -3.6Cr -24Cr -9.52Cr -118.89Cr -9.42Cr -9.22Cr -410.77Cr -2.75Cr -2.42Cr -2.25Cr -2.07Cr -3.88Cr -263.18Cr -3.95Cr -27Cr -10Cr -130.52Cr -10Cr -10Cr -450.95Cr
Net Debt -1.34Cr -1.18Cr -1.1Cr -1.01Cr -1.89Cr -128.02Cr -1.92Cr -13Cr -5.09Cr -63Cr -5.03Cr -4.92Cr -219.35Cr -2.14Cr -1.88Cr -1.75Cr -1.61Cr -3.02Cr -204.45Cr -3.07Cr -21Cr -8.12Cr -101.39Cr -8.03Cr -7.86Cr -350.31Cr
Logo Clene Inc.
Clene Inc. is a clinical-stage pharmaceutical company, which is engaged in discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The CSN therapeutics are comprised of atoms of transition elements that, when assembled in nanocrystal form, possess unusually high, unique catalytic activities that do not present in those same elements in bulk form. CNM-Au8, the lead drug asset, is a concentrated aqueous suspension of catalytically active, clean-surfaced, faceted gold nanocrystals for the treatment of ALS, MS, and PD. CNM-Au8's mechanism of action targets mitochondrial dysfunction by catalyzing the production of nicotinamide adenine dinucleotide. Its CNM-ZnAg is an antiviral and antibacterial agent comprised of zinc (Zn2+) and silver (Ag+) ions in an aqueous solution to treat infectious disease and to provide immune support for symptom resolution.
Employees
78
Date Price Change Volume
29/26/29 $4.990 -8.61% 92,370
27/26/27 $5.460 +1.30% 28,258
24/26/24 $5.390 -1.64% 48,257
23/26/23 $5.480 -5.84% 85,518
22/26/22 $5.820 -0.51% 42,792
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
5.460USD
Average target price
32.20USD
Spread / Average Target
+489.74%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CLNN Stock